
Parquest et al. carve out Sopral from Avril Group
Several investors led by Parquest Capital have completed the purchase of France-based Sopral, a specialist in nutritional products for animals, from the Avril Group.
Parquest has become the majority shareholder of the business, investing alongside its current management team. In addition, Idia Capital Investissement, Agro Invest and Unexo now hold minority stakes in the business.
Sopral had been an Avril subsidiary since 2010. Avril became a minority shareholder in Sopral via its finance and development company Sofiproteol, and will therefore continue to support the future development of the company.
Company
Founded in 1957, Sopral is specialised in the formulation, production and sale in around 50 countries of nutritional products for dogs, cats and horses. It operates two production units in Pléchâtel and administrative offices in Pont-Réan.
People
Sopral – Yannick Gueho (general manager).
Parquest Capital – Denis Le Chevallier (partner).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater